Contact Allergies May Help Stymie Cancer

New data suggests that skin rashes are associated with lower risk of developing certain cancers.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA COMMONS, ORRLING AND TOMER SCHEIB

People who get skin rashes when exposed to certain metals or chemicals may be less likely to develop some types of cancer, according to a study published yesterday (July 11) in the journal BMJ Open.

Earlier epidemiological studies comparing medical histories and allergies (usually self-reported) revealed a lower incidence of certain cancers in allergic people than in those without allergies. The studies supported the hypothesis that an overactive immune system—which causes adverse reactions to dust, cats, and pollen—also provides better protection against cancer, killing cells with cancerous potential before they become problematic. (Read our Feature on this topic, Immune System Vs. Cancer.)

However, there are differences in how the immune system is activated in different allergies. An association between lower cancer rates and immediate allergies ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Edyta Zielinska

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours